Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Ruifulai Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise located in the Yuci Industrial Park of Jinzhong, Shanxi Province, China. Founded in 2002, the company integrates drug research, development, production, and sales, focusing on both chemical pharmaceuticals and traditional Chinese medicine (TCM). Its extensive product catalog covers therapeutic areas such as respiratory health, cardiovascular disease, and metabolic disorders, with key products including metformin hydrochloride and compound liquorice tablets. Ruifulai operates multiple GMP-certified production lines for oral solid dosages, including tablets, capsules, and granules. The company serves as a significant regional player in the Chinese domestic drug supply chain, emphasizing quality control and standardized manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山西瑞福莱.